edited by George F. Vande Woude, ABL-Basic Research Program, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland, George Klein, Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden